| Primary |
| Breast Cancer |
36.8% |
| Breast Cancer Metastatic |
11.0% |
| Non-small Cell Lung Cancer |
11.0% |
| Premedication |
8.4% |
| Hypertension |
3.4% |
| Pain |
3.2% |
| Cardiac Failure Congestive |
3.1% |
| Pancreatic Carcinoma Metastatic |
3.1% |
| Endometrial Cancer |
2.7% |
| Nausea |
2.2% |
| Nutritional Support |
1.9% |
| Anaemia |
1.8% |
| Prostate Cancer |
1.8% |
| Arthritis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Headache |
1.4% |
| Menopausal Symptoms |
1.4% |
| Neoplasm |
1.4% |
| Supplementation Therapy |
1.2% |
| Chest Pain |
0.8% |
|
| Vomiting |
19.3% |
| Neutropenia |
7.3% |
| Weight Decreased |
7.3% |
| White Blood Cell Count Decreased |
7.3% |
| Sepsis |
6.0% |
| Septic Shock |
4.7% |
| Blood Creatinine Increased |
4.0% |
| Death |
4.0% |
| Pyrexia |
4.0% |
| Renal Failure Acute |
4.0% |
| Thrombocytopenia |
4.0% |
| Urinary Incontinence |
4.0% |
| Dizziness |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Embolism |
3.3% |
| Sudden Death |
3.3% |
| Atrial Fibrillation |
2.7% |
| Bone Pain |
2.7% |
| Headache |
2.7% |
| Hypovolaemia |
2.7% |
|
| Secondary |
| Breast Cancer |
37.5% |
| Breast Cancer Metastatic |
10.6% |
| Drug Use For Unknown Indication |
8.5% |
| Non-small Cell Lung Cancer |
8.1% |
| Product Used For Unknown Indication |
6.7% |
| Endometrial Cancer |
5.0% |
| Hypertension |
3.4% |
| Premedication |
3.2% |
| Neoplasm Malignant |
2.6% |
| Nausea |
2.5% |
| Pain |
2.3% |
| Endometrial Cancer Recurrent |
2.2% |
| Medical Diet |
1.3% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Arthritis |
1.0% |
| Neoplasm |
1.0% |
| Inflammatory Carcinoma Of The Breast |
0.9% |
| Constipation |
0.7% |
| Pancreatic Carcinoma Metastatic |
0.7% |
| Anaemia |
0.6% |
|
| Vomiting |
23.6% |
| White Blood Cell Count Decreased |
9.6% |
| Pyrexia |
7.6% |
| Febrile Neutropenia |
6.4% |
| Pulmonary Embolism |
5.1% |
| Thrombocytopenia |
5.1% |
| Neuropathy Peripheral |
3.8% |
| Septic Shock |
3.8% |
| Stomatitis |
3.8% |
| Death |
3.2% |
| Osteonecrosis |
3.2% |
| Peripheral Sensory Neuropathy |
3.2% |
| Pleural Effusion |
3.2% |
| Sepsis |
3.2% |
| Abdominal Pain |
2.5% |
| Cerebrovascular Accident |
2.5% |
| Fatigue |
2.5% |
| Nausea |
2.5% |
| Platelet Count Decreased |
2.5% |
| Pneumonitis |
2.5% |
|
| Concomitant |
| Breast Cancer |
34.1% |
| Breast Cancer Metastatic |
13.2% |
| Drug Use For Unknown Indication |
9.6% |
| Product Used For Unknown Indication |
7.2% |
| Metastases To Bone |
6.6% |
| Pain |
6.0% |
| Deep Vein Thrombosis |
4.2% |
| Osteonecrosis |
4.2% |
| Nausea |
3.0% |
| Metaplasia |
2.4% |
| Abdominal Discomfort |
1.8% |
| Abdominal Distension |
1.8% |
| Pulmonary Embolism |
1.8% |
| Blood Pressure |
1.2% |
| Constipation |
1.2% |
| Breast Cancer Female |
0.6% |
| Prophylaxis |
0.6% |
| Thrombosis Prophylaxis |
0.6% |
|
| Weight Decreased |
15.6% |
| Vomiting |
12.5% |
| Unresponsive To Stimuli |
9.4% |
| Disease Progression |
6.3% |
| Pericardial Drainage |
6.3% |
| Uterine Cervical Squamous Metaplasia |
6.3% |
| Decreased Appetite |
3.1% |
| Drug Ineffective |
3.1% |
| Fistula Discharge |
3.1% |
| Grand Mal Convulsion |
3.1% |
| Influenza Like Illness |
3.1% |
| Metastases To Central Nervous System |
3.1% |
| Metastases To Retroperitoneum |
3.1% |
| Muscle Atrophy |
3.1% |
| Muscle Spasms |
3.1% |
| Pain |
3.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.1% |
| Pulmonary Embolism |
3.1% |
| Rash |
3.1% |
| Recurrent Cancer |
3.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Renal Failure Acute |
100.0% |
|
